Tennessee’s governor rejected $8.8 million in federal grant money for HIV prevention and detection; Senator Bernie Sanders pleads for drug price decrease in his first drug hearing as health chair; the prevalence of autism is growing, with children of color more likely to be diagnosed compared with White children for the first time.
Tennessee’s Rejection of $8.8M Federal Dollars Panics HIV Prevention Groups
Tennessee Governor Bill Lee (R) rejected $8.8 in federal funding for HIV prevention and detection, reported The New York Times. Tennessee is the only state to reject this federal funding, with the governor planning to use $9 million in new state funding for HIV monitoring and prevention in July. Despite this, some organizations are worried that the state won’t offer them vital funding if they do not align with the governor’s conservative beliefs regarding transgender rights and abortion access.
Senator Sanders Pleads for Drug Price Decreases in Committee Hearing
In a hearing with the Committee on Health, Education, Labor, and Pensions, Senator Bernie Sanders used his new platform as chair of the committee to vehemently voice his beliefs on drug prices, according to Kaiser Health News. The committee has very little power over drug prices, which is under the jurisdiction of the Finance Committee that oversees Medicaid, Medicare, and the Affordable Care Act. This prompted a more aggressive approach from Sanders because of this limited power that ended with the senator pleading with Moderna’s CEO for a small concession on vaccine pricing, to which the CEO made no promises.
Rising Autism Rates, More Children of Color Being Diagnosed, Details New Data
A new study found that autism rates grew in the years Between 2018 and 2020, rates of autism grew from 1 in 44 children to 1 in 36 diagnosed, reported USA Today. The new data found that, for the first time, White children are less likely to carry the diagnosis than children of color. These years hold the most recent data for autism, with the increase being attributed to more children of color getting the help they need, said the chief science officer at autism advocacy group Autism Speaks. However, one of the authors on the study noted that it is unknown why autism prevalence is increasing and it should be considered a “major public health crisis.”
House lawmakers are expected to advance a contracting ban today on 5 Chinese research firms; US government officials temporarily relaxed strict guidelines on how laboratories handle, store, and transport H5N1 bird flu samples; a recent report found that the number of abortions occurring in the US continued to grow despite bans.
Read More
Patients With MG Report Higher Azathioprine Discontinuation vs Other Immunosuppressants
May 15th 2024Survey data from over 200 patients showed that treatment discontinuation was lower for those taking mycophenolate or methotrexate than for those taking azathioprine for their myasthenia gravis (MG).
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study
May 15th 2024This real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.
Read More
Valoctocogene Roxaparvovec Dramatically Reduces Bleeding in Hemophilia A
May 15th 2024New study findings demonstrate that valoctocogene roxaparvovec, a gene therapy for severe hemophilia A, significantly reduces bleeding episodes and dependency on factor VIII infusions over a 3-year period, while maintaining a favorable safety profile.
Read More